Data as of Jan 27
| +0.03 / +0.51%|
The 2 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 8.50, with a high estimate of 10.00 and a low estimate of 7.00. The median estimate represents a +44.07% increase from the last price of 5.90.
The current consensus among 3 polled investment analysts is to Buy stock in Accretive Health Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.